SCHEMBL30962797

SCHEMBL30962797

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)nc(-c2c(Cl)cccc2Cl)c1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 3/20 0.47
▸ ALK Q9UM73 2/20 0.44
▸ EHMT2 Q96KQ7 1/20 0.42
▸ CCNT1 O60563 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ CDK6 Q00534 1/20 0.38
▸ CDK11A Q9UQ88 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ PAK1 Q13153 3/20 0.37
▸ EGFR P00533 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ TNK2 Q07912 1/20 0.36
▸ FLT4 P35916 1/20 0.36
▸ TBK1 Q9UHD2 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ MET P08581 1/20 0.36
▸ AXL P30530 1/20 0.36
▸ MERTK Q12866 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962777 0.98 WEE1 (0.46) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962727 0.95 ALK (0.45) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962694 0.95 WEE1 (0.44) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962810 0.95 WEE1 (0.44) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962877 0.94 WEE1 (0.44) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962700 0.93 WEE1 (0.43) WEE1ALKEHMT2CCNT1CDK4
SCHEMBL30962632 0.93 WEE1 (0.43) WEE1ALKEHMT2CCNT1CDK9
SCHEMBL30962824 0.93 WEE1 (0.42) WEE1ALKEHMT2CDK4CDK6
SCHEMBL30962806 0.93 WEE1 (0.43) WEE1ALKEHMT2EGFRFLT4
SCHEMBL30962911 0.92 WEE1 (0.48) WEE1ALKEHMT2CCNT1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback